Great Lakes Pharmaceuticals, Inc.: Series B $3.1M

Posted in I - Series B, Q - 3Q10, R - MID WEST, X - Antibacterial, X - Device (Catheter), X - Drug:Device Combo, XX - OH

Great Lakes Pharmaceuticals (Cleveland, OH) a clinical-stage drug:device company focused on catheter-related bloodstream infection, closed a $3.1M Series B financing. Participants include Charter Life Sciences, Early Stage Partners, Ohio Tech Angels and North Coast Angel Fund.

Sep

2009

Akebia Therapeutics, Inc.: Series A $16M

Posted in I - Series A, Q - 3Q09, R - MID WEST, X - Anemia, X - Vascular, XX - OH

Akebia Therapeutics (Cincinnati, OH) a clinical-stage biopharmaceutical company focused on the development of small-molecules for anemia and vascular disease, closed a $16M Series A bringing the total financing to $25M. Participants include Novartis Venture Fund, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners and Sigvion Capital.

May

2009

CerviLenz, Inc.: Series A $4M

Posted in I - Series A, Q - 2Q09, R - MID WEST, X - Device (GYN), X - Device (OBY), XX - OH

CerviLenz (Chagrin Falls, OH) a commercial-stage developer of a diagnostic single-use medical device for measuring cervical length to determine the risk of pre-term birth in pregnant women, closed a $4M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.

to top of page...